152 related articles for article (PubMed ID: 37555273)
21. Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy.
Song H; Cai Z; Li J; Xiao H; Qi R; Zheng M
J Nanobiotechnology; 2022 Jul; 20(1):329. PubMed ID: 35842642
[TBL] [Abstract][Full Text] [Related]
22. Rationally Integrated Precise ER-Targeted and Oxygen-Compensated Photodynamic Immunostimulant for Immunogenicity-Boosted Tumor Therapy.
Qian Y; Wang M; Xie Y; Sun Q; Gao M; Li C
Adv Healthc Mater; 2023 Dec; 12(32):e2301728. PubMed ID: 37602576
[TBL] [Abstract][Full Text] [Related]
23. ROS-responsive Galactosylated-nanoparticles with Doxorubicin Entrapment for Triple Negative Breast Cancer Therapy.
Zhou J; Li K; Zang X; Xie Y; Song J; Chen X
Int J Nanomedicine; 2023; 18():1381-1397. PubMed ID: 36987427
[TBL] [Abstract][Full Text] [Related]
24. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
[TBL] [Abstract][Full Text] [Related]
25. MnO
Zhang L; Yang R; Yu H; Xu Z; Kang Y; Cui H; Xue P
J Mater Chem B; 2021 May; 9(17):3677-3688. PubMed ID: 33949613
[TBL] [Abstract][Full Text] [Related]
26. Combined Photosensitive Gene Therapy Effective Against Triple-Negative Breast Cancer in Mice Model.
Hu Y; Wang D; Zhang T; Lei M; Luo Y; Chen Z; Li Y; Duan D; Zhang L; Zhu Y
Int J Nanomedicine; 2024; 19():1809-1825. PubMed ID: 38414523
[TBL] [Abstract][Full Text] [Related]
27. Harnessing chlorin e6 loaded by functionalized iron oxide nanoparticles linked with glucose for target photodynamic therapy and improving of the immunogenicity of lung cancer.
Yu TT; Peng XC; Wang MF; Han N; Xu HZ; Li QR; Li LG; Xu X; Ma QL; Liu B; Wang J; Zhao L; Chen X; Li TF
J Cancer Res Clin Oncol; 2022 Apr; 148(4):867-879. PubMed ID: 34997349
[TBL] [Abstract][Full Text] [Related]
28. Doxorubicin-loaded pH-responsive nanoparticles coated with chlorin e6 for drug delivery and synergetic chemo-photodynamic therapy.
Liang J; Jin X; Chen B; Hu J; Huang Q; Wan J; Hu Z; Wang B
Nanotechnology; 2020 May; 31(19):195103. PubMed ID: 31978912
[TBL] [Abstract][Full Text] [Related]
29. Beta-carotene-bound albumin nanoparticles modified with chlorin e6 for breast tumor ablation based on photodynamic therapy.
Phuong PTT; Lee S; Lee C; Seo B; Park S; Oh KT; Lee ES; Choi HG; Shin BS; Youn YS
Colloids Surf B Biointerfaces; 2018 Nov; 171():123-133. PubMed ID: 30025374
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy.
Deng X; Zhao R; Song Q; Zhang Y; Zhao H; Hu H; Zhang Z; Liu W; Lin W; Wang G
Drug Deliv; 2022 Dec; 29(1):3142-3154. PubMed ID: 36164704
[TBL] [Abstract][Full Text] [Related]
31. Multifunctional biomimetic nanoplatform based on photodynamic therapy and DNA repair intervention for the synergistic treatment of breast cancer.
Wu H; Du X; Xu J; Kong X; Li Y; Liu D; Yang X; Ye L; Ji J; Xi Y; Zhai G
Acta Biomater; 2023 Feb; 157():551-565. PubMed ID: 36513248
[TBL] [Abstract][Full Text] [Related]
32. Triple-negative breast cancer treatment in xenograft models by bifunctional nanoprobes combined to photodynamic therapy.
Dos Santos Jesus VP; Vieira PFA; Cintra RC; Sant'Anna LB; Zezell DM; Castilho ML; Raniero L
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102796. PubMed ID: 35263669
[TBL] [Abstract][Full Text] [Related]
33. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
[TBL] [Abstract][Full Text] [Related]
34. Light-activatable Chlorin e6 (Ce6)-imbedded erythrocyte membrane vesicles camouflaged Prussian blue nanoparticles for synergistic photothermal and photodynamic therapies of cancer.
Sun L; Li Q; Hou M; Gao Y; Yang R; Zhang L; Xu Z; Kang Y; Xue P
Biomater Sci; 2018 Oct; 6(11):2881-2895. PubMed ID: 30192355
[TBL] [Abstract][Full Text] [Related]
35. Platelet-biomimetic nanoparticles for in vivo targeted photodynamic therapy of breast cancer.
Song Y; Tan X; Gao Y
J Biomater Sci Polym Ed; 2022 Aug; 33(11):1383-1397. PubMed ID: 35321618
[TBL] [Abstract][Full Text] [Related]
36. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
[TBL] [Abstract][Full Text] [Related]
37. Tumor-specific activated photodynamic therapy with an oxidation-regulated strategy for enhancing anti-tumor efficacy.
Liang H; Zhou Z; Luo R; Sang M; Liu B; Sun M; Qu W; Feng F; Liu W
Theranostics; 2018; 8(18):5059-5071. PubMed ID: 30429886
[TBL] [Abstract][Full Text] [Related]
38. Novel carrier-free nanoparticles composed of 7-ethyl-10-hydroxycamptothecin and chlorin e6: Self-assembly mechanism investigation and in vitro/in vivo evaluation.
Zhao Y; Zhao Y; Ma Q; Zhang H; Liu Y; Hong J; Ding Z; Liu M; Han J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110722. PubMed ID: 31887649
[TBL] [Abstract][Full Text] [Related]
39. Immune/Hypoxic Tumor Microenvironment Regulation-Enhanced Photodynamic Treatment Realized by pH-Responsive Phase Transition-Targeting Nanobubbles.
Zhao M; Yang X; Fu H; Chen C; Zhang Y; Wu Z; Duan Y; Sun Y
ACS Appl Mater Interfaces; 2021 Jul; 13(28):32763-32779. PubMed ID: 34235912
[TBL] [Abstract][Full Text] [Related]
40. Nanodrug Inducing Autophagy Inhibition and Mitochondria Dysfunction for Potentiating Tumor Photo-Immunotherapy.
Xiao H; Li X; Li B; Yang S; Qin J; Han S; Ren J; Shuai X
Small; 2023 Jul; 19(30):e2300280. PubMed ID: 37060227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
